Australian biotech market today 23.04.09
Thursday, 23 April, 2009
A very flat day’s trading on the healthcare index today, in line with the rest of stocks, which were generally in the positive but volumes were small.
Biota (ASX:BTA) is up 12c on news that royalties from Relenza for the quarter will total $32.3 million.
Circadian (ASX:CIR) was up 3c, as was Clinuvel (ASX:CLV), up 2c to 32c.
Cochlear (ASX:COH) was substantially down again, to $48.3, while Pharmaxis (ASX:PXS) was up a touch.
Diversa (ASX:DVA) was up slightly on its reinstatement to trading.
Anti-inflammatory drug may help treat alcohol use disorder
A drug that is already FDA-approved for treating inflammatory conditions may help reduce both...
Osteoarthritis study uncovers new genetic links, drug targets
The genome-wide association study (GWAS) uncovered over 900 genetic associations, more than 500...
How brain cells are affected by Tourette syndrome
US researchers have conducted a cell-by-cell analysis of brain tissue from individuals with...
